ClinicalTrials.Veeva

Menu

Novofine Autocover Safety Needle Versus BD Safety Glide

Novo Nordisk logo

Novo Nordisk

Status and phase

Completed
Phase 4

Conditions

Diabetes
Healthcare Professionals
Delivery Systems

Treatments

Device: autocover needle
Device: safety glide

Study type

Interventional

Funder types

Industry

Identifiers

NCT00121355
MS241-1674

Details and patient eligibility

About

This trial is conducted in the United States of America (USA). The aim of this trial is to examine whether nurses prefer to use the NovoFine® Autocover Needle or the BD Safety Glide (TM) Syringe (only) in a hospital setting. The number of needle stick injuries will also be evaluated and whether these hospital nurses prefer the safety features of the NovoFine® Autocover Needle versus those of the BD Safety Glide (TM) Syringe. The identified hospital nurses will evaluate the two types of needles during standard administration of insulin to patients being treated for diabetes.

Enrollment

83 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

  • Hospital nurses with prior injection training without an infectious blood borne disease

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

None (Open label)

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems